CAMKMT
Calmodulin-lysine N-methyltransferase
Also known as: C2orf34, CLNMT, CMKMT_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z624
- Gene
- CAMKMT
- Ensembl
- ENSG00000143919
- Chromosome
- 2
- Canonical length
- 323 aa
- Protein class
- Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
This gene encodes a class I protein methyltransferase that acts in the formation of trimethyllysine in calmodulin. The protein contains a AdoMet-binding motif and may play a role in calcium-dependent signaling. [provided by RefSeq, Sep 2012]
Canonical amino-acid sequenceUniProt
323 residues, UniProt reviewed canonical sequence.
>Q7Z624|CAMKMT
1 MESRVADAGT GETARAAGGS PAVGCTTRGP VVSAPLGAAR WKLLRQVLKQ KHLDDCLRHV
61 SVRRFESFNL FSVTEGKERE TEEEVGAWVQ YTSIFCPEYS ISLRHNSGSL NVEDVLTSFD
121 NTGNVCIWPS EEVLAYYCLK HNNIFRALAV CELGGGMTCL AGLMVAISAD VKEVLLTDGN
181 EKAIRNVQDI ITRNQKAGVF KTQKISSCVL RWDNETDVSQ LEGHFDIVMC ADCLFLDQYR
241 ASLVDAIKRL LQPRGKAMVF APRRGNTLNQ FCNLAEKAGF CIQRHENYDE HISNFHSKLK
301 KENPDIYEEN LHYPLLLILT KHGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CAMKMT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 14 nTPM
- testis: 12 nTPM
- cerebral cortex: 11 nTPM
- hypothalamus: 9.4 nTPM
- amygdala: 9.2 nTPM
- pancreas: 9.2 nTPM
Single-cell type
- myonuclei: 598 nCPM
- choroid plexus epithelial cells: 531 nCPM
- retinal ganglion cells: 514 nCPM
- distal convoluted tubule cells: 485 nCPM
- neutrophil progenitors: 442 nCPM
- loop of henle epithelial cells: 426 nCPM
Immune cell
- memory B-cell: 21 nTPM
- T-reg: 18 nTPM
- naive CD4 T-cell: 17 nTPM
- naive B-cell: 15 nTPM
- naive CD8 T-cell: 13 nTPM
- basophil: 13 nTPM
Brain region
- basal ganglia: 30 nTPM
- cerebellum: 27 nTPM
- white matter: 26 nTPM
- hypothalamus: 24 nTPM
- choroid plexus: 24 nTPM
- thalamus: 23 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CAMKMT.
Disease | AllUniProt
Conditions CAMKMT is implicated in, by any mechanism.
- Hypotonia-cystinuria syndrome (HCS) MIM:606407
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.52
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.14
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- heat shock protein binding
- calmodulin-lysine N-methyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Lysine methyltransferase
- S-adenosyl-L-methionine-dependent methyltransferase superfamily
- Lysine methyltransferase
- Calmodulin-lysine N-methyltransferase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CAMKMT in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
- HSP90
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CAMKMT as an antibody target. Whether an autoantibody or antibody against CAMKMT could matter depends on whether native CAMKMT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CAMKMT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CAMKMT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...